1. Adelaide Research & Scholarship

Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-10 of 25 (Search time: 0.009 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2008Effect of long-chain polyunsaturated fatty acid supplementation of preterm infants on disease risk and neurodevelopment: a systematic review of randomized controlled trialsSmithers, L.; Gibson, R.; McPhee, A.; Makrides, M.
2022Neonatal Docosahexaenoic Acid in Preterm Infants and Intelligence at 5 YearsGould, J.F.; Makrides, M.; Gibson, R.A.; Sullivan, T.R.; McPhee, A.J.; Anderson, P.J.; Best, K.P.; Sharp, M.; Cheong, J.L.Y.; Opie, G.F.; Travadi, J.; Bednarz, J.M.; Davis, P.G.; Simmer, K.; Doyle, L.W.; Collins, C.T.
2023Predictors of compliance with higher dose omega-3 fatty acid supplementation during pregnancy and implications for the risk of prematurity: exploratory analysis of the ORIP randomised trialSullivan, T.R.; Yelland, L.N.; Gibson, R.A.; Thakkar, S.K.; Huang, F.; Best, K.P.; Devaraj, S.; Zolezzi, I.S.; Makrides, M.
2019A randomized trial of prenatal n-3 fatty acid supplementation and preterm deliveryMakrides, M.; Best, K.; Yelland, L.; McPhee, A.; Zhou, S.; Quinlivan, J.; Dodd, J.; Atkinson, E.; Safa, H.; van Dam, J.; Khot, N.; Dekker, G.; Skubisz, M.; Anderson, A.; Kean, B.; Bowman, A.; McCallum, C.; Cashman, K.; Gibson, R.
2021Protocol for assessing if behavioural functioning of infants born <29 weeks' gestation is improved by omega-3 long-chain polyunsaturated fatty acids: follow-up of a randomised controlled trialGould, J.F.; Roberts, R.M.; Anderson, P.J.; Makrides, M.; Sullivan, T.R.; Gibson, R.A.; McPhee, A.J.; Doyle, L.W.; Opie, G.; Travadi, J.; Cheong, J.L.Y.; Davis, P.G.; Sharp, M.; Simmer, K.; Tan, K.; Morris, S.; Lui, K.; Bolisetty, S.; Liley, H.; Stack, J.; et al.
2006Marine oil, and other prostaglandin precursor, supplementation for pregnancy uncomplicated by pre-eclampsia or intrauterine growth restrictionMakrides, M.; Duley, L.; Olsen, S.
2023Effect of Docosahexaenoic Acid (DHA) Supplementation of Preterm Infants on Growth, Body Composition, and Blood Pressure at 7-Years Corrected Age: Follow-Up of a Randomized Controlled TrialBest, K.P.; Sullivan, T.R.; Gunaratne, A.W.; Gould, J.F.; Gibson, R.A.; Collins, C.T.; Makrides, M.; Green, T.J.
2023Identifying women who may benefit from higher dose omega-3 supplementation during pregnancy to reduce their risk of prematurity: exploratory analyses from the ORIP trial.Yelland, L.N.; Sullivan, T.R.; Gibson, R.A.; Simmonds, L.A.; Thakkar, S.K.; Huang, F.; Devaraj, S.; Best, K.P.; Zolezzi, I.S.; Makrides, M.
2021Recent advances in policy and practice translation of the evidence for additional omega-3 fatty acids and prematuritySimmonds, L.A.; Middleton, P.F.; Makrides, M.
2001Randomized trials with polyunsaturated fatty acid interventions in preterm and term infants: Functional and clinical outcomesGibson, R.; Chen, W.; Makrides, M.

Discover